TR200001971T2 - Nevronların birleşmesinde karşılığı geliştirmek için benzoksazin bileşikler. - Google Patents

Nevronların birleşmesinde karşılığı geliştirmek için benzoksazin bileşikler.

Info

Publication number
TR200001971T2
TR200001971T2 TR2000/01971T TR200001971T TR200001971T2 TR 200001971 T2 TR200001971 T2 TR 200001971T2 TR 2000/01971 T TR2000/01971 T TR 2000/01971T TR 200001971 T TR200001971 T TR 200001971T TR 200001971 T2 TR200001971 T2 TR 200001971T2
Authority
TR
Turkey
Prior art keywords
neurons
compounds
association
improve
improve response
Prior art date
Application number
TR2000/01971T
Other languages
English (en)
Inventor
A. Rogers Gary
Marrs Christopher
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of TR200001971T2 publication Critical patent/TR200001971T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

AMPA alicilari tarafindan yayilan nevronlarin birlesmesitik karsililari gelistirmek için kullanisli, belirli bir benzoksazin halka sistemine sahip bilesikler ve bunlarin habercileri açiklanmaktadir. Ayrica bu tür bilesikleri hazirlamak için yöntemler ve bunlarin harekete geçirici nevronlarin birlesmelerinin sayisindaki veya AMPA alicilarinin sayisindaki eksiklikler yüzünden zarar verici sinirsel veya zihinsel islemeden sikinti çeken öznelerin tedavisinde kullanimi için yöntemler açiklanmaktadir. Bulusun bilesikleri, AMPA alicilarini kullanan betin sebekelerine bagli duyumsal-motor ve bilissel islerdeki performansini gelistirmek için zarar görmemis öznelerin tedavisi ve hafiza kodlamasini gelistirmek için de kullanilabilmektedir.
TR2000/01971T 1997-12-24 1998-12-16 Nevronların birleşmesinde karşılığı geliştirmek için benzoksazin bileşikler. TR200001971T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/998,300 US5985871A (en) 1997-12-24 1997-12-24 Benzoxazine compounds for enhancing synaptic response

Publications (1)

Publication Number Publication Date
TR200001971T2 true TR200001971T2 (tr) 2001-01-22

Family

ID=25545024

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01971T TR200001971T2 (tr) 1997-12-24 1998-12-16 Nevronların birleşmesinde karşılığı geliştirmek için benzoksazin bileşikler.

Country Status (22)

Country Link
US (1) US5985871A (tr)
EP (1) EP1054673B1 (tr)
JP (1) JP4620244B2 (tr)
KR (1) KR100561049B1 (tr)
CN (1) CN1160360C (tr)
AT (1) ATE261306T1 (tr)
AU (1) AU746971B2 (tr)
BR (1) BR9814478A (tr)
CA (1) CA2316356C (tr)
DE (1) DE69822344T2 (tr)
DK (1) DK1054673T3 (tr)
ES (1) ES2217615T3 (tr)
HU (1) HUP0102056A3 (tr)
IL (1) IL136783A (tr)
MX (1) MXPA00006155A (tr)
NO (1) NO325764B1 (tr)
NZ (1) NZ505212A (tr)
PL (1) PL194905B1 (tr)
PT (1) PT1054673E (tr)
RU (1) RU2246497C2 (tr)
TR (1) TR200001971T2 (tr)
WO (1) WO1999033469A1 (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110935A (en) 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses
US6124278A (en) * 1998-04-03 2000-09-26 The Regents Of The University Of California Acylbenzoxazines for enhancing synaptic response
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
TWI232863B (en) * 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
NZ529671A (en) 2001-06-14 2005-10-28 Akzo Nobel Nv (Pyrido/thieno)-[f]-oxazepin-5-one derivatives
EA200501117A1 (ru) 2003-01-13 2006-02-24 Кортекс Фармасеутикалс, Инк. Способ лечения снижения когнитивной способности вследствие лишения сна и стресса
WO2006034196A1 (en) * 2004-09-17 2006-03-30 Lifelike Biomatic Inc. Compositions for enhancing memory and methods therefor
PL2144506T3 (pl) * 2007-01-03 2012-04-30 Servier Lab 3-podstawiony-[1,2,3]-benzotriazynon jako związek do wzmacniania odpowiedzi glutaminianergicznych
EA200900937A1 (ru) * 2007-01-03 2009-12-30 Кортекс Фармасеутикалс, Инк. Соединения 3-замещенного-[1,2,3]бензотриазинона для усиления глутаматергических синаптических ответов
KR101599661B1 (ko) 2007-05-17 2016-03-03 코텍스 파마슈티칼스, 인크. 글루타메이트에 의한 시냅스 반응을 향상시키기 위한 이치환된 아미드 화합물
US8119632B2 (en) 2007-08-10 2012-02-21 Cortex Pharmaceuticals, Inc. Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
BRPI0823262A2 (pt) 2007-08-10 2013-09-24 Cortex Pharma Inc mÉtodo de tratamento de depressço respiratària e uso de um composto na fabricaÇço de um medicamento para o tratamento de depressço respiratària
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
AU2012225784B2 (en) 2011-03-04 2016-03-17 The Regents Of The University Of California Locally released growth factors to mediate motor recovery after stroke
SG193327A1 (en) * 2011-04-06 2013-10-30 Taiho Pharmaceutical Co Ltd Novel imidazo-oxazine compound or salt thereof
AU2014277952A1 (en) 2013-06-13 2016-01-28 Veroscience Llc Compositions and methods for treating metabolic disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ255097A (en) * 1992-07-24 2001-04-27 Univ California Heterocyclic derivatives (such as 1-(1,4-bgenzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine) and medicaments that enhance synaptic responses
JPH0943929A (ja) * 1995-05-19 1997-02-14 Matsushita Electric Ind Co Ltd 電子写真複写装置
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response

Also Published As

Publication number Publication date
KR20010033615A (ko) 2001-04-25
BR9814478A (pt) 2000-10-10
WO1999033469A1 (en) 1999-07-08
MXPA00006155A (es) 2002-04-24
CA2316356A1 (en) 1999-07-08
RU2246497C2 (ru) 2005-02-20
CN1283114A (zh) 2001-02-07
JP4620244B2 (ja) 2011-01-26
ES2217615T3 (es) 2004-11-01
NZ505212A (en) 2003-02-28
CN1160360C (zh) 2004-08-04
DE69822344T2 (de) 2005-02-17
NO20003166D0 (no) 2000-06-19
ATE261306T1 (de) 2004-03-15
EP1054673A1 (en) 2000-11-29
CA2316356C (en) 2009-11-03
PL341427A1 (en) 2001-04-09
HUP0102056A3 (en) 2003-03-28
DK1054673T3 (da) 2004-07-05
IL136783A (en) 2005-11-20
NO325764B1 (no) 2008-07-14
EP1054673A4 (en) 2001-07-18
PL194905B1 (pl) 2007-07-31
EP1054673B1 (en) 2004-03-10
NO20003166L (no) 2000-08-07
US5985871A (en) 1999-11-16
PT1054673E (pt) 2004-08-31
KR100561049B1 (ko) 2006-03-16
IL136783A0 (en) 2001-06-14
AU746971B2 (en) 2002-05-09
DE69822344D1 (de) 2004-04-15
JP2001527045A (ja) 2001-12-25
AU1930599A (en) 1999-07-19
HUP0102056A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
TR200001971T2 (tr) Nevronların birleşmesinde karşılığı geliştirmek için benzoksazin bileşikler.
DK0891365T3 (da) Benzoxaziner til forstærkning af synaptiske responser
TR199801302T2 (tr) Ikame edilmis aza ve diazasikolopentan ve siklooktan bilesikleri.
ID23374A (id) Halogenopirimidin
PT1169370E (pt) Solucoes de poliuretano contendo unidades estruturais de alcoxissilano.
PT772603E (pt) Compostos substituidos de pirimidina e sua utilizacao
BR8008411A (pt) Processos de preparacao de um eletrodo, de oxidos, de cloro e de revestimento e eletrodo
TR200000152T2 (tr) Yeni bileşikler.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
DE69510545T2 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
ES8500225A1 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
TR200002072T2 (tr) Spiropiperidin türevleri
DE69910552D1 (de) Acylbenzoxazine zur erhöhung der synaptischen reaktion(en)
DE69936779D1 (de) Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
ATE318142T1 (de) Verwendung von spezifischen 'steady-state' calcium-r-kanalblockern
PT1017377E (pt) Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina
IL59956A0 (en) Trans-1-(piperidino-and morpholino-alkyl)-4-tert.butylcylohexane compounds,their preparation and their use as anti-mycotic agents
BR9711960A (pt) Verapamil como um medicamento para o tratamento de angina
TR199800705T2 (tr)
ATE35219T1 (de) 2-acylimidazolverbindungen, deren herstellung und verwendung als immunosuppressive heilmittel.
ATE165166T1 (de) Paracetamolphosphat für immunoassays
SU634252A1 (ru) Регул тор освещенности
SU866971A1 (ru) Циклопентено[d]тиазолил-2-гидразон n-нитробензальдегида, обладающий инсектицидной активностью
SU803383A1 (ru) Гидрохлорид 3,3,6-триметил-1,2,3,4-тетрагидроиндоло/2,3-с/хинолина, обладающий антидепрессантной активностью
IT8421215A0 (it) Alchilammine n-sostituite, loro produzione e loro impiego come sostanze ad attivita'antimicrobica.